Our overall goal, as you know, on both sides of the aisle is to see to it that the Congress produces effective legislation that will actually lower the price of prescription drugs for the American people.

the rising drug costs and need for greater transparency in the whole chain.

Today's hearing focuses on a health crisis facing American families--the soaring costs of prescription drugs.

But Congress is going to move and we want to move together so that we end up keeping the promise to the American people that their prescription drug will not bankrupt them or allow them to die without them; because that is really what it…

There is a saying in politics: follow the money.

I support them 100 percent. I hope we can get rid of DIR fees.

I especially appreciate Mr. Kennedy's questionings, especially around the biosimilar market.

We're going to follow the money. We're examining the system from beginning to end because in order to fix it, we must understand it, and then, we're going to act.

I think it is one of the reasons that we wanted you here today; so that the small bio people would have a voice in the hearing and in policymaking.

I am proud of the bipartisan work, but it is critical that we recognize that the work cannot and will not stop there.

it is my hope that we might consider Federal legislation regarding transparency.

I think we are really very happy to have this session here today to try to untangle the drug supply chain.